Allergan Shows Off Phase III Migraine Data Post author:Sam Post published:February 5, 2018 Post category:BioPharma The ACHIEVE I study included 1327 U.S. adult patients. Source: BioSpace You Might Also Like Heptares Founder Shares Her Best Life Sciences Career Advice November 21, 2017 InVivo Therapeutics Announces Seventh Patient Conversion In The INSPIRE Study Of The Neuro-Spinal Scaffold March 27, 2017 Veracyte Launches Campaign To Save Lives Through Early Screening For Lung Cancer September 18, 2017
InVivo Therapeutics Announces Seventh Patient Conversion In The INSPIRE Study Of The Neuro-Spinal Scaffold March 27, 2017
